Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/21714539

J. Med. Chem. 2011 Aug 11 54 15 5607-11

Download in:

View as

Triples

General Info

PMID
21714539